UCL Press Release
Under embargo until Thursday 11 September 2025, 00:01 UK time
Peer reviewed, qualitative study
Study sheds light on hurdles faced in transforming NHS healthcare with AI
Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools and staff training, finds a major new UK study led by UCL researchers.
Authors of the study, published in The Lancet eClinicalMedicine, say the findings should provide timely and useful learning for the UK Government, whose recent 10-year NHS plan identifies digital transformation, including AI, as a key platform to improving the service and patient experience.
In 2023, NHS England launched a programme to introduce AI to help diagnose chest conditions, including lung cancer, across 66 NHS hospital trusts in England, backed by £21 million in funding. The trusts are grouped into 12 imaging diagnostic networks: these hospital networks mean more patients have access to specialist opinions. Key functions of these AI tools included prioritising critical cases for specialist review and supporting specialists’ decisions by highlighting abnormalities on scans.
Funded by the National Institute for Health and Care Research (NIHR), this research was conducted by a team from UCL, the Nuffield Trust, and the University of Cambridge, analysing how procurement and early deployment of the AI tools went. The study is one of the first studies to analyse real-world implementation of AI in healthcare.
Evidence from previous studies¹, mostly laboratory-based, suggested that AI might benefit diagnostic services by supporting decisions, improving detection accuracy, reducing errors and easing workforce burdens.
In this UCL-led study, the researchers reviewed how the new diagnostic tools were procured and set up through interviews with hospital staff and AI suppliers, identifying any pitfalls but also any factors that helped smooth the process.
They found that setting up the AI tools took longer than anticipated by the programme’s leadership. Contracting took between four and 10 months longer than anticipated and by June 2025, 18 months after contracting was meant to be completed, a third (23 out of 66) of the hospital trusts were not yet using the tools in clinical practice.
Key challenges included engaging clinical staff with already high workloads in the project, embedding the new technology in ageing and varied NHS IT systems across dozens of hospitals and a general lack of understanding, and scepticism, among staff about using AI in healthcare.
The study also identified important factors which helped embed AI including national programme leadership and local imaging networks sharing resources and expertise, high levels of commitment from hospital staff leading implementation, and dedicated project management.
The researchers concluded that while “AI tools may offer valuable support for diagnostic services, they may not address current healthcare service pressures as straightforwardly as policymakers may hope” and are recommending that NHS staff are trained in how AI can be used effectively and safely and that dedicated project management is used to implement schemes like this in the future.
First author Dr Angus Ramsay (UCL Department of Behavioural Science and Health) said: “In July ministers unveiled the Government’s 10-year plan for the NHS, of which a digital transformation is a key platform.
“Our study provides important lessons that should help strengthen future approaches to implementing AI in the NHS.
“We found it took longer to introduce the new AI tools in this programme than those leading the programme had expected.
“A key problem was that clinical staff were already very busy – finding time to go through the selection process was a challenge, as was supporting integration of AI with local IT systems and obtaining local governance approvals. Services that used dedicated project managers found their support very helpful in implementing changes, but only some services were able to do this.
“Also, a common issue was the novelty of AI, suggesting a need for more guidance and education on AI and its implementation.
“AI tools can offer valuable support for diagnostic services, but they may not address current healthcare service pressures as simply as policymakers may hope.”
The researchers conducted their evaluation between March and September last year, studying 10 of the participating networks and focusing in depth on six NHS trusts. They interviewed network teams, trust staff and AI suppliers, observed planning, governance and training and analysed relevant documents.
Some of the imaging networks and many of the hospital trusts within them were new to procuring and working with AI.
The problems involved in setting up the new tools varied – for example, in some cases those procuring the tools were overwhelmed by a huge amount of very technical information, increasing the likelihood of key details being missed. Consideration should be given to creating a national approved shortlist of potential suppliers to facilitate procurement at local level, the researchers said.
Another problem was initial lack of enthusiasm among some NHS staff for the new technology in this early phase, with some more senior clinical staff raising concerns about the potential impact of AI making decisions without clinical input and on where accountability lay in the event a condition was missed. The researchers found the training offered to staff did not address these issues sufficiently across the wider workforce – hence their call for early and ongoing training on future projects.
In contrast, however, the study team found the process of procurement was supported by advice from the national team and imaging networks learning from each other. The researchers also observed high levels of commitment and collaboration between local hospital teams (including clinicians and IT) working with AI supplier teams to progress implementation within hospitals.
Senior author Professor Naomi Fulop (UCL Department of Behavioural Science and Health) said: “In this project, each hospital selected AI tools for different reasons, such as focusing on X-ray or CT scanning, and purposes, such as to prioritise urgent cases for review or to identify potential symptoms.
“The NHS is made up of hundreds of organisations with different clinical requirements and different IT systems and introducing any diagnostic tools that suit multiple hospitals is highly complex. These findings indicate AI might not be the silver bullet some have hoped for but the lessons from this study will help the NHS implement AI tools more effectively.”
Limitations
While the study has added to the very limited body of evidence on the implementation and use of AI in real-world settings, it focused on procurement and early deployment. The researchers are now studying the use of AI tools following early deployment when they have had a chance to become more embedded. Further, the researchers did not interview patients and carers and are therefore now conducting such interviews to address important gaps in knowledge about patient experiences and perspectives, as well as considerations of equity.
Ends
Notes to editors
For more information or to speak to the researchers involved, please contact Nick Hodgson, UCL Media Relations. T: +44 (0)7769 240209, E: nick.hodgson@ucl.ac.uk
Angus I.G. Ramsay, Nadia Crellin, Rachel Lawrence, Holly Walton, Stuti Bagri, Emma Dodsworth, Holly Elphinstone, Fergus Gleeson, Amanda Halliday, Kevin Herbert, Joanne Lloyd, Efthalia Massou, Raj Mehta, Stephen Morris, Pei Li Ng, Tracy O'Regan, Chris Sherlaw-Johnson and Naomi J. Fulop, ‘Procurement and early deployment of artificial intelligence tools for chest diagnostics in NHS services in England: A rapid, mixed method evaluation’ will be published in The Lancet e-Clinical Medicine on Wednesday 10 September 2025, 00:01 UK time and is under a strict embargo until this time.
The DOI will be https://doi.org/10.1016/j.eclinm.2025.103481.
¹ Liu M, Wu J, Wang N, Zhang X, Bai Y, Guo J, et al, The value of artificial intelligence in the diagnosis of lung cancer: A systematic review and meta-analysis; Joy Mathew C, David AM, Joy Mathew CM, Artificial Intelligence and its future potential in lung cancer screening; Chiu HY, Chao HS, Chen YM, Application of Artificial Intelligence in Lung Cancer.; and Lawrence R, Dodsworth E, at al, Artificial intelligence for diagnostics in radiology practice: a rapid systematic scoping review.
In January, the Government announced a shake-up in the use of technology and AI across the NHS and other public services.
About UCL – London’s Global University
UCL is a diverse global community of world-class academics, students, industry links, external partners, and alumni. Our powerful collective of individuals and institutions work together to explore new possibilities.
Since 1826, we have championed independent thought by attracting and nurturing the world's best minds. Our community of more than 50,000 students from 150 countries and over 16,000 staff pursues academic excellence, breaks boundaries and makes a positive impact on real world problems.
The Times and Sunday Times University of the Year 2024, we are consistently ranked among the top 10 universities in the world and are one of only a handful of institutions rated as having the strongest academic reputation and the broadest research impact.
We have a progressive and integrated approach to our teaching and research – championing innovation, creativity and cross-disciplinary working. We teach our students how to think, not what to think, and see them as partners, collaborators and contributors.
For almost 200 years, we are proud to have opened higher education to students from a wide range of backgrounds and to change the way we create and share knowledge.
We were the first in England to welcome women to university education and that courageous attitude and disruptive spirit is still alive today. We are UCL.
www.ucl.ac.uk | Read news at www.ucl.ac.uk/news/ | Follow UCL News on Bluesky and LinkedIn
About NIHR
The mission of the National Institute for Health and Care Research (NIHR) is to improve the health and wealth of the nation through research.
We do this by:
funding high quality, timely research that benefits the NHS, public health and social care
investing in world-class expertise, facilities and a skilled delivery workforce to translate discoveries into improved treatments and services
partnering with patients, service users, carers and communities, improving the relevance, quality and impact of our research
attracting, training and supporting the best researchers to tackle complex health and social care challenges
collaborating with other public funders, charities and industry to help shape a cohesive and globally competitive research system funding applied global health research and training to meet the needs of the poorest people in low and middle income countries
NIHR is funded by the Department of Health and Social Care.
Its work in low and middle income countries is principally funded through UK international development funding from the UK government.
END